- $18.42bn
- $18.63bn
- $4.61bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,716 | 2,507 | 4,117 | 4,602 | 4,606 |
Cost of Revenue | |||||
Gross Profit | 820 | 1,324 | 2,367 | 2,807 | 2,492 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,779 | 3,369 | 4,819 | 5,997 | 6,004 |
Operating Profit | -1,063 | -862 | -702 | -1,395 | -1,398 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1,033 | -926 | -474 | -1,401 | -1,294 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,034 | -945 | -488 | -1,430 | -1,322 |
Net Income Before Extraordinary Items | |||||
Net Income | -1,034 | -945 | -488 | -1,430 | -1,322 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,034 | -945 | -488 | -1,430 | -1,322 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.77 | -0.649 | -0.313 | -0.813 | -0.804 |